2019 Satellite Symposia Schedule

Satellite Symposia will be offered in the following times (subject to review and approval of content).

Monday Dinner, February 4, 2019, 6:30 – 8:30 PM
Unraveling a Therapeutic Conundrum: ASMD Niemann Pick Disease
CME Satellite Symposium. Accredited provider: EXCEL Continuing Education.
Supported by an educational grant from Sanofi Genzyme.

Monday Dinner, February 4, 2019, 6:30 – 8:30 PM
Bridging the Gap Between Research and Clinical Advances in Gaucher Disease Type 3
CME Satellite Symposium. Accredited provider: MedIQ.
Supported by an educational grant from Sanofi Genzyme.

Tuesday Breakfast, February 5, 2019, 6:15 – 7:15 AM
Monitoring Disease Burden and Assessing the Biochemical, Cellular and Clinical Response to Therapy in Fabry Disease
Supported by Sanofi Genzyme.
This satellite is open only to registered attendees from outside the United States. International participants only.

Tuesday Breakfast, February 5, 2019, 6:15 – 7:15 AM
Advances in the Diagnosis of MPS Disorders
Supported by Ultragenyx Pharmaceutical.

Tuesday Lunch, February 5, 2019, 11:45 AM – 12:45 PM
Treatment Experience in CLN2 Disease – New 3.5 Year Data and Case Review
Supported by BioMarin Pharmaceutical Inc.

Tuesday Lunch, February 5, 2019, 11:45 AM – 12:45 PM
Biomarkers: Ready for Prime Time in the Clinical Management of Lysosomal Diseases?
Supported by Shire.

Tuesday Dinner, February 5, 2019, 6:30 – 8:30 PM
Sphingolipids: Opening the Black Box
Supported by Sanofi Genzyme.

Tuesday Dinner, February 5, 2019, 6:30 – 8:30 PM
An Evening of Stories with Friends: How Academics, Patients, and Industry Collaborate to Develop New Therapies for Pompe Disease and Other Lysosomal Disorders
Supported by Amicus Therapeutics, Inc.

Wednesday Breakfast, February 6, 2019, 6:15 – 7:15 AM
The Case for a First-Line, Long-Term Oral Treatment Option for Eligible Adult Gaucher Type 1 Patients
Supported by Sanofi Genzyme.

Wednesday Breakfast, February 6, 2019, 6:15 – 7:15 AM
Satellite Space Available.

Wednesday Lunch, February 6, 2019, 11:45 AM – 12:45 PM
Precision Medicine in Fabry Disease: A New Approach to Treat the Classic Phenotype Patient
Supported by Amicus Therapeutics, Inc.

Wednesday Lunch, February 6, 2019, 11:45 AM – 12:45 PM
Moving Forward to Optimal Management of MPS IVA and VI Patients
Supported by BioMarin Pharmaceutical Inc.

Wednesday Dinner, February 6, 2019, 6:30 – 8:30 PM
Hand in Hand: A Patient and Physician Journey in Pompe Disease
Supported by Sanofi Genzyme.

Wednesday Dinner, February 6, 2019, 6:30 – 8:30 PM
TOO RARE? Facing Diagnostic and Clinical Development Challenges in Alpha-mannosidosis
Supported by Chiesi Farmaceutici S.p.A.
This satellite is open only to registered attendees from outside the United States. International participants only.

Thursday Breakfast, February 7, 2019, 6:15 – 7:15 AM
Fabry Disease: Treatment Guidelines to Optimize Patient Outcomes
Supported by Sanofi Genzyme.

Thursday Breakfast, February 7, 2019, 6:15 – 7:15 AM
Satellite Space Available.

Thursday Lunch, February 7, 2019, 11:45 AM – 12:45 PM
Managing Fabry Disease – Current Real World Evidence and Future Advances
Supported by Amicus Therapeutics, Inc.
This satellite is open only to registered attendees from outside the United States. International participants only.

Thursday Lunch, February 7, 2019, 11:45 AM – 12:45 PM
Growth and Skeletal Complications in MPS: Future Directions
Supported by Sanofi Genzyme.

Registration for the 15th Annual Scientific Meeting and an official WORLDSymposium name badge are required to attend any of the satellite symposia.

Titles and content for Satellite Symposia will be posted as information becomes available.

These Satellite Symposia are not part of the official WORLDSymposium™ 2019 program, and WORLDSymposium does not approve or endorse any commercial products or services discussed during these Symposia or offered for sale by the corporate supporter of the Symposium. These Symposia may or may not offer CME credits; these sessions are not approved for CME through WORLDSymposium.